Peter Parsons
Member
Scientific Advisory Committee
Ecobiotics Limited
Australia
Biography
Professor Peter Parsons is Senior Principal Research Fellow and head of the Drug Discovery Group at the Queensland Institute of Medical Research. His research interests are signalling pathways in tumor cells and novel therapies for cancer, including interpretation of pharmacogenomic profiles for anticancer agents, bioactivity-guided purification of natural products, and validation of drugs in tumor models in vivo.Professor Parsons holds a PhD in organic chemistry from the University of Adelaide. After postdoctoral studies in the UK on biosynthesis of natural products he moved to the University of Queensland and later the Queensland Institute of Medical Research. He published some of the first evidence for anticancer efficacy of histone deacetylase inhibitors, and continues collaboration with medicinal chemists. His group played a major role in preclinical development and commercial manufacture of a skin cancer drug currently in clinical trials by Peplin Ltd.A conjoint professor in the School of Medicine, the University of Queensland, Professor Parsons has published 190 papers, is co-author on 5 patents, supervises 3 postgraduate students, and is a member of 4 professional societies.
Research Interest
Medical Sciences
